Hunt Ventures

Hunt Ventures is a Dallas-based life sciences venture capital firm focusing on Series B investments. The firm typically invests in companies within the biotechnology and pharmaceutical sectors, aiming to support innovative solutions in healthcare. Hunt Ventures has a notable presence in the U.S. market, particularly in Texas, where it leverages its regional expertise to identify promising opportunities.

Notable portfolio companies include Macrogenics, which has raised $43.1 million, and Peptimmune, with $41.2 million in funding. The firm's key partners bring extensive industry experience and strategic insight, contributing to the success of their investments. Hunt Ventures offers unique value-add services such as strategic advisory and operational support to help portfolio companies scale effectively and achieve their growth objectives.